Rational approach to discover multipotent anti-Alzheimer drugs

被引：232

作者：

Rosini, M

Andrisano, V

Bartolini, M

Bolognesi, ML

Hrelia, P

Minarini, A

Tarozzi, A

Melchiorre, C

机构：

[1] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy

[2] Univ Bologna, Dept Pharmacol, I-40126 Bologna, Italy

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2005年 / 48卷 / 02期

关键词：

D O I：

10.1021/jm049112h

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The coupling of two different pharmacophores, each endowed with different biological properties, afforded the hybrid compound lipocrine (7), whose biological profile was markedly improved relative to those of prototypes tacrine and lipoic acid. Lipocrine is the first compound that inhibits the catalytic activity of AChE and AChE-induced amyloid-beta aggregation and protects against reactive oxygen species. Thus, it emerged as a valuable pharmacological tool to investigate Alzheimer's disease and as a promising lead compound for new anti-Alzheimer drugs.

引用

页码：360 / 363

页数：4

共 50 条

[31] Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning
Kabir, Md Tanvir
Uddin, Md Sahab
Begum, Marium
Thangapandiyan, Shanmugam
Rahman, Md Sohanur
Aleya, Lotfi
Mathew, Bijo
Ahmed, Muniruddin
Barreto, George E.
Ashraf, Ghulam Md
CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (33) : 3519 - 3535
[32] Novel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer's Agents: Design, Synthesis and Biological Evaluation
Spilovska, Katarina
Korabecny, Jan
Sepsova, Vendula
Jun, Daniel
Hrabinova, Martina
Jost, Petr
Muckova, Lubica
Soukup, Ondrej
Janockova, Jana
Kucera, Tomas
Dolezal, Rafael
Mezeiova, Eva
Kaping, Daniel
Kuca, Kamil
MOLECULES, 2017, 22 (06):
[33] Interaction between anti-Alzheimer and antipsychotic drugs in modulating extrapyramidal motor disorders in mice
Shimizu, Saki
Mizuguchi, Yuto
Sobue, Akira
Fujiwara, Mai
Morimoto, Tomoki
Ohno, Yukihiro
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 127 (04) : 439 - 445
[34] Novel multifunctional anti-Alzheimer drugs with various CNS neurotransmitter targets and neuroprotective moieties
Van der Schyf, Cornelis J.
Mandel, Silvia
Geldenhuys, Werner J.
Amit, Tamar
Avramovich, Yael
Zheng, Hailin
Fridkin, Mati
Gal, Shunit
Weinreb, Orly
Bar Am, Orit
Sagi, Yotam
Youdim, Moussa B. H.
CURRENT ALZHEIMER RESEARCH, 2007, 4 (05) : 522 - 536
[35] A QSAR Study on the Biological Activities of Polyamines as Anti-alzheimer Drugs by Monte Carlo Optimization
Ghasemi, Ghasem
JOURNAL OF SCIENTIFIC & INDUSTRIAL RESEARCH, 2019, 78 (05): : 323 - 327
[36] Effects of Anti-Alzheimer Drugs on Phosphorylation and Assembly of Microtubules from Brain Microtubular Proteins
Shevtsov, P. N.
Shevtsova, E. F.
Burbaeva, G. Sh.
Bachurin, S. O.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2014, 156 (06) : 768 - 772
[37] Anti-Alzheimer's Drugs: Hepatobiliary Toxicity, Data from the French Pharmacovigilance Database
Maura, Geric
Vallet, Catherine
Nouasria, Imane
Herlem, Emmanuelle
Trenque, Thierry
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S307 - S307
[38] Curcuminoids and resveratrol as anti-Alzheimer agents
Villaflores, Oliver B.
Chen, Ying-Ju
Chen, Chih-Ping
Yeh, Jui-Ming
Wu, Tzong-Yuan
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2012, 51 (04): : 515 - 525
[39] Effects of Anti-Alzheimer Drugs on Phosphorylation and Assembly of Microtubules from Brain Microtubular Proteins
P. N. Shevtsov
E. F. Shevtsova
G. Sh. Burbaeva
S. O. Bachurin
Bulletin of Experimental Biology and Medicine, 2014, 156 : 768 - 772
[40] Discovery of Potent Human Glutaminyl Cyclase Inhibitors as Anti-Alzheimer's Agents Based on Rational Design
Van-Hai Hoang
Phuong-Thao Tran
Cui, Minghua
Ngo, Van T. H.
Ann, Jihyae
Park, Jongmi
Lee, Jiyoun
Choi, Kwanghyun
Cho, Hanyang
Kim, Hee
Ha, Hee-Jin
Hong, Hyun-Seok
Cho, Sun
Kim, Young-Ho
Lee, Jeewoo
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (06) : 2573 - 2590

← 1 2 3 4 5 →